Differential Cardiometabolic Effects of GLP-1 Receptor Agonists Versus SGLT2 Inhibitors in Early-Onset Type 2 Diabetes: A Randomized Controlled Trial. Link Medical Journal, [S. l.], v. 4, n. 1, p. 1–9, 2026. DOI: 10.61919/061x6w21. Disponível em: https://linkmjhcr.com/index.php/lmj/article/view/189. Acesso em: 7 jul. 2026.